Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Tissue Microarray Market Size Changed, over the years?

The size of the tissue microarray market has seen considerable growth in the past few years. It is forecasted to expand from $12.05 billion in 2024 to $13.23 billion in 2025, with a compound annual growth rate (CAGR) of 9.8%. The growth during the historical period can be associated with the emergence of precision medicine, advancements in drug discovery and development, efficient analysis, an increase in chronic diseases, and biobanking initiatives.

How Much Will the Tissue Microarray Market Be Worth in 2029?

In the upcoming years, the tissue microarray market is anticipated to witness a significant growth in its size. With a compound annual growth rate of 12.2%, it’s projected to reach $20.95 billion by 2029. The expected growth during the forecast period is due to factors such as the advent of digital pathology, increased applications, the expansion of the biopharmaceutical industry, regulatory reinforcement and standards, as well as the integration of AI and machine learning. Key trends for the forecast period include advances in imaging technologies, the creation of 3D tissue microarrays, high-content screening, initiatives for standardization, and the incorporation of single-cell analysis.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12236&type=smp

Which is the Largest Company in the Tissue Microarray Market?

Major companies operating in the tissue microarray market include Roche Group, Merck & Co. Inc., Thermo Fisher Scientific Inc., Becton, Dickinson Biosciences, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, PerkinElmer Inc., Bio-Techne Corporation, Tristar Group, Evotec SE, Precision For Medicine Inc., Molecular Devices LLC, BioIVT LLC, BioChain Institute Inc., Creative Bioarray Co, 3DHISTECH Ltd., Novus Biologicals LLC, PREMIER Biosoft International Inc., iSpecimen Inc., OriGene Technologies Inc., Bio SB Inc., ProteoGenex Inc., Z Biotech LLC

What Are the Main Market Drivers in the Tissue Microarray Industry?

As the incidence of cancer continues to rise, so is the anticipated expansion of the tissue microarray market. Cancer, a broad spectrum of diseases that occurs when cells grow out of control, break through their natural boundaries, and invade other organs or neighboring tissues, is profoundly affecting any organ or tissue in the body. Tissue arrays play a critical role in oncology by facilitating the analysis of cancer-related biomarkers in diverse tumor specimens. In June 2022, reports from the British cancer charity, Macmillan Cancer Support, indicated that the number of cancer patients had reached 3 million in 2022 and is predicted to soar close to 3.5 million by 2025 and 4 million by 2030, specifically in the UK. Thus, the increasing prevalence of cancer is fueling the upward trajectory of the tissue microarray market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12236&type=smp

How Is the Tissue Microarray Market Segments Structured?

The tissue microarray market covered in this report is segmented –

1) By Type: Immunohistochemistry, Fluorescent In Situ Hybridization, Frozen Tissue Array, Other Types

2) By Technology: Deoxyribonucleic Acid (DNA) Microarray, Polymerase Chain Reaction (PCR), Next-Generation Sequencing, Northern Blotting, Western Blotting

3) By Application: Oncology, Gene Expression Profiling, Single Nucleotide Polymorphism (SNP) Detection, Double-Stranded B-DNA Microarrays, Comparative Genomic Hybridization, Sequencing Bioinformatics

4) By End-User: Pharmaceutical And Biotechnological Companies, Research Organization, Hospitals

Subsegments:

1) By Immunohistochemistry: Automated Immunohistochemistry, Manual Immunohistochemistry, Multiplex Immunohistochemistry

2) By Fluorescent In Situ Hybridization (FISH): Single-Color FISH, Multi-Color FISH, DNA FISH

3) By Frozen Tissue Array: Tissue Microarray from Frozen Samples, Snap-Frozen Tissue Array

4) By Other Types: Nucleic Acid Microarrays, RNA In Situ Hybridization, Paraffin-Embedded Tissue Array

What Strategic Trends Are Transforming the Tissue Microarray Market?

Forming strategic alliances is becoming increasingly popular in the tissue microarray industry. Companies in this field are entering partnerships to forge new relations for the development of tissue microarray technologies. For instance, in November 2022, The Cureline Group, an American CRO specializing in translational and precision medicine, providing HBS biobanking and lab services, collaborated with Cellecta Inc., an American firm offering RNAi and CRISPR screening products and services. The partnership, called Tissue 2 Target Services, combines the companies’ crucial skills in molecular analysis of cells and tissue and human biospecimen management. Their goal is to provide pre-clinical and translational research facilities that specialize in gene target and biomarker discovery services to optimize workflows. Moreover, in September 2022, a strategic collaboration was initiated between Ultivue Inc., an American biotech company that creates reagent-based solutions for maximizing the biological data from cells and tissue samples, and ngTMA, a TRU platform originating from the University of Bern in Switzerland that designs innovative workflows for tissue microarray construction. The objective of this collaboration is to improve multiplexed immunofluorescence (mIF) assays, employ new TMA technologies for spatial analysis in scientific research, and upgrade the quality of TMAs used in clinical and translational research.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report

Which Global Regions Offer the Highest Growth in the Tissue Microarray Market?

North America was the largest region in the tissue microarray market in 2024. Asia-Pacific is expected to be the fastest-growing region in the tissue microarray market report during the forecast period. The regions covered in the tissue microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12236

This Report Delivers Insight On:

1. How big is the tissue microarray market, and how is it changing globally?

2. Who are the major companies in the tissue microarray market, and how are they performing?

3. What are the key opportunities and risks in the tissue microarray market right now?

4. Which products or customer segments are growing the most in the tissue microarray market?

5. What factors are helping or slowing down the growth of the tissue microarray market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model